Triglyceride disposition in isolated hepatocytes after treatment with hydrazine

Chemico-Biological Interactions

Volumn 107, Issue 3, 1997, Pages 157-172

  Waterfield, Catherine J ^a   Asker, Daniel S ^a   Timbrell, John A ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

oxidation; Hydrazine; Isolated hepatocytes; Triglyceride synthesis

Indexed keywords

HYDRAZINE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG DISPOSITION; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; LIPOGENESIS; LIVER CELL; LIVER METABOLISM; NONHUMAN; RAT; STEM CELL;

ANIMALS; BIOLOGICAL TRANSPORT; CARBON DIOXIDE; CARBON RADIOISOTOPES; CELL SEPARATION; HYDRAZINES; LIVER; MALE; OXIDATION-REDUCTION; PALMITATES; RATS; RATS, WISTAR; TRIGLYCERIDES;

ANIMALIA;

EID: 0031465181     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00090-2     Document Type: Article

References (29)

1. Amenta J.S., Johnson E.H. Hydrazine induced alterations in rat liver. A correlation of the chemical and histological changes in acute hydrazine intoxication. Lab. Invest. 11:1962;956-962.
2. Timbrell J.A., Scales M.D.C., Streeter A.J. Studies on hydrazine hepatotoxicity. 2. Biochemical findings. J. Toxicol. Environ. Health. 10:1982;955-968.
3. Jenner A.M., Timbrell J.A. Effect of acute and repeated exposure to low doses of hydrazine on hepatic microsomal enzymes and biochemical parameters in vivo. Toxicology. 68:1994;240-245.
4. Blair I.A., Mansilla-Tinoco R., Brodie M.J., Clare R.A., Dollery C.T., Timbrell J.A., Beever I.A. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Hum. Toxicol. 4:1985;195-202.
5. Timbrell J.A., Harland S.J. Identification and quantification of hydrazine in the urine of patients treated with hydralazine. Clin. Pharmacol. Ther. 26:1979;81-88.
6. Gold J. Hydrazine sulphate: a current perspective. Nutr. Cancer. 9:1987;9-66.
7. M.U. Dianzani, Biochemical aspects of fatty liver, in: R.G. Meeks, S.D. Harrison, R.J. Bull (Eds.), Hepatotoxicity, CRC Press, Boca Raton, FL, 1991, pp. 327-400.
8. Trout D.L. Effects of hydrazine on fat transport as affected by glucose concentration. J. Pharmacol. Exp. Ther. 152:1966;529-534.
9. Clark D.A., Leeder L.G., Foulds E.I., Trout D.L. Changes in lipids of rat liver after hydrazine injection. Biochem. Pharmacol. 19:1970;1743-1752.
10. Preece N.E., Ghatineh S., Timbrell J.A. Course of ATP depletion in hydrazine hepatotoxicity. Arch. Toxicol. 64:1990;49-53.
11. Farber E. Ethionine fatty liver. Adv. Lipid Res. 5:1967;119-183.
12. Jenner A.M., Timbrell J.A. Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo. Arch. Toxicol. 68:1994;349-357.
13. Lopez-Mendoza D., Villa-Trevino S. Hydrazine-induced inhibition of amino acid incorporation into rat liver protein. Lab. Invest. 25:1971;68-72.
14. Sanins S.M., Nicholson J.K., Elcombe C., Timbrell J.A. Hepatotoxin-induced hypertaurinuria: a proton NMR study. Arch. Toxicol. 64:1990;407-411.
15. Waterfield C.J., Turton J.A., Scales M.D.C., Timbrell J.A. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 67:1993;244-254.
16. Waterfield C.J., Asker D.S., Timbrell J.A. Does urinary taurine reflect changes in protein metabolism? A study with cycloheximide in rats. Biomarkers. 1:1996;107-114.
17. Lamb R.G., Banks W.L. Effect of hydrazine exposure on hepatic triacylglycerol biosynthesis. Biochim. Biophys. Acta. 574:1979;440-447.
18. Haghighi B., Honarjou S. The effects of hydrazine on the phosphatidate phosphohydrolase activity in rat liver. Biochem. Pharmacol. 36:1987;1163-1166.
19. A. Martin, A. Gomez-Muñoz, Z. Jamal, D.N. Brindley, Characterization and assay of phosphatidate phosphatase, in: Methods in Enzymology, vol. 197, Academic Press, New York, 1991, pp. 553-563.
20. Deboyser D., Goethals F., Krack G., Roberfroid M. Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes. Toxicol. Appl. Pharmacol. 97:1989;473-479.
21. M.N. Berry, A.M. Edwards, G.J. Barritt, in: Isolated Hepatocytes Preparation, Properties and Applications, Elsevier, Amsterdam, 1991, pp. 172-173.
22. Moldeus P., Hogberg J., Orrenius S. Isolation and use of liver cells. Methods Enzymol. 52:1978;60-71.
23. Marshall C.E., Watts D.I., Sugden M.C. Effects of hydrazine on liver and brown adipose tissue lipogenesis in 24 h-starved rats. J. Pharm. Pharmacol. 35:1983;460-461.
24. J. Girard, M.-I. Malewiak, Fatty acid oxidation and ketogenesis in isolated hepatocytes, in: A. Guillouzo, C. Guguen-Guillouzo (Eds.), Research in Isolated and Cultured Hepatocytes, Libby, London, 1986, pp. 87-112.
25. H.U. Bergmeyer, E. Bernt, B. Hess, Lactate dehydrogenase, in: H.U. Bergmeyer (Ed.), Methods in Enzymatic Analysis, Academic Press, New York, 1965, pp. 736-743.
26. Stanley P.E., Williams S.G. Use of the liquid scintillation spectrometer for determining adenosine triphosphate by luciferase enzyme. Anal. Biochem. 29:1969;381-392.
27. F. Goethals, M. Roberfroid, Alternatives for testing hepatotoxicity, in: C.L. Galli, A.M. Goldberg, M. Marinovich (Eds.), Modulation of Cellular Responses in Toxicity, Series H: Cell Biology, vol. 93, NATO ASI Series (Advanced Science Institutes Series) Springer, UK, 1995, pp. 265-281.
28. Waterfield C.J., Delaney J., Kerai M.D.J., Timbrell J.A. Correlations between in vivo and in vitro effects of toxic compounds: Studies with hydrazine. Toxicol. Vitro. 11:1997;217-227.
29. Carfagna M.A., Held S.D., Kedderis G.L. Furan-induced cytolethality in isolated rat hepatocytes: correspondence with in vivo dosimetry. Toxicol. Appl. Pharmacol. 123:1993;265-273.